辰光医疗
(430300)
| 流通市值：12.98亿 | | | 总市值：16.75亿 |
| 流通股本：6653.17万 | | | 总股本：8584.71万 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 86,106,323.16 | 57,154,824.55 | 20,859,112.75 | 165,644,428.37 |
| 营业收入 | 86,106,323.16 | 57,154,824.55 | 20,859,112.75 | 165,644,428.37 |
| 二、营业总成本 | 115,412,560.94 | 76,954,002.08 | 30,698,379.49 | 179,395,354.49 |
| 营业成本 | 50,568,766.55 | 32,667,911.9 | 10,186,735.54 | 107,650,908.52 |
| 税金及附加 | 1,062,775.14 | 652,974.95 | 359,154.3 | 1,896,394.58 |
| 销售费用 | 23,137,000.76 | 15,857,078.76 | 7,432,956.77 | 18,946,206.29 |
| 管理费用 | 19,366,422.93 | 14,008,614.98 | 5,762,963.22 | 27,464,920.06 |
| 研发费用 | 17,729,835.43 | 11,515,845.64 | 6,033,462.71 | 20,049,634.39 |
| 财务费用 | 3,547,760.13 | 2,251,575.85 | 923,106.95 | 3,387,290.65 |
| 其中:利息费用 | 3,677,688.04 | 2,430,745.52 | 1,163,114.31 | 3,697,146.36 |
| 其中:利息收入 | 201,471.42 | 157,099.55 | 103,506.75 | 525,141.1 |
| 加:投资收益 | 389,185.83 | 272,736.48 | 373.8 | 619,038.77 |
| 资产处置收益 | -7,317.13 | -7,317.13 | - | -996,326.93 |
| 资产减值损失(新) | 407,054.03 | 527,859.98 | - | -1,886,605.37 |
| 信用减值损失(新) | 5,494,327.63 | 3,467,461.97 | - | -9,616,774.42 |
| 其他收益 | 2,868,011.89 | 1,453,970.85 | 646,611.07 | 6,040,733.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -20,154,975.53 | -14,084,465.38 | -9,192,281.87 | -19,590,860.31 |
| 加:营业外收入 | 158,439.06 | 155,438.99 | 145,438.02 | 3,000,050.86 |
| 减:营业外支出 | 256 | 307 | 227 | 145,992.11 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -19,996,792.47 | -13,929,333.39 | -9,047,070.85 | -16,736,801.56 |
| 减:所得税费用 | -4,121,455.63 | -2,722,282.16 | 8,394.22 | -4,232,425.44 |
| 六、净利润 | -15,875,336.84 | -11,207,051.23 | -9,055,465.07 | -12,504,376.12 |
| 持续经营净利润 | -15,875,336.84 | - | -9,055,465.07 | -12,504,376.12 |
| 归属于母公司股东的净利润 | -15,875,336.84 | -11,207,051.23 | -9,055,465.07 | -11,782,726.74 |
| 少数股东损益 | - | - | - | -721,649.38 |
| (一)基本每股收益 | -0.18 | -0.13 | -0.11 | -0.14 |
| (二)稀释每股收益 | -0.18 | -0.13 | -0.11 | -0.14 |
| 九、综合收益总额 | -15,875,336.84 | -11,207,051.23 | -9,055,465.07 | -12,504,376.12 |
| 归属于母公司股东的综合收益总额 | -15,875,336.84 | -11,207,051.23 | -9,055,465.07 | -11,782,726.74 |
| 归属于少数股东的综合收益总额 | - | - | - | -721,649.38 |
| 公告日期 | 2024-10-30 | 2024-08-27 | 2024-04-26 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |